Shouzheng Innovation to the Future • The Summit of the Research and Innovation Achievement Research and Innovation Achievements of Chinese Medicine was held at Shijiazhuang

On July 6, the Management Committee of Shijiazhuang High -tech Industrial Development Zone, Hebei Pharmaceutical Association, Hebei Provincial Pharmaceutical Industry Association, and World Chinese Medicine Association Joint Society of Medicine Corporation and other joint sponsored The Summit Forum with Innovation Achievement Transformation "was held in Shijiazhuang. Zhang Boyi, Cong Bin, Zhang Yun, Yang Baofeng, Yu Jinming, Tian Jinzhou, Wu Yiling and other academicians, as well as Li Yigui, a master of Chinese medicine, and well -known experts and scholars from the Chinese medicine industry from all over the country gathered through the way The important achievements of theoretical inheritance, innovation, and transformation have conducted in -depth exchanges.

Zhang Boli, an academician of the Chinese Academy of Engineering and the honorary title of the "People's Heroes" national honor, Zhan Peng, deputy mayor of Shijiazhuang City, Liu Xiaozhen, chairman of the Hebei Pharmaceutical Association, and Liu Xiaozhen, secretary of the Party Branch of the Hebei Medical Industry Association. The transformation of theoretical research and innovation results of the theoretical of neat disease has provided a useful reference to promote the construction of the Chinese medicine scientific and technological innovation system and the development of traditional Chinese medicine.

Academician Zhang Boli delivered a speech at the meeting.

Academician Zhang Boli pointed out that the theory of linked disease is an important achievement of modern Chinese medicine research and a model of inheritance and innovation of traditional Chinese medicine. The theoretical system system built by Academician Wu Yiling has clarified the diagnostic standards, scope of applications, and modern biological mechanisms. Under the guidance of the theoretical of the neat pathology, it has developed through the heart of the heart, ginseng pine, and osteophytes, and even the flowers clearing the plague. Waiting for Tongluo Drugs, a series of strict evidence -based medical evaluations were conducted at the same time, which achieved good results in the prevention and treatment of major clinical diseases. The holding of the study and innovation achievement of traditional Chinese medicine linked diseases is of great significance to how to better apply the theory of neat disease to major diseases to prevent and control the general public.

In the academician salon, academicians exchanged exchanges on the transformation of the research and innovation achievements of traditional Chinese medicine.

The system builds a theoretical system of neat disease to establish a new subject of traditional Chinese medicine linked diseases to promote the development of the industry

Inheritance, innovation and development of Chinese medicine is an important part of the cause of socialism with Chinese characteristics in the new era. List disease is one of the typical representatives of the essence of Chinese medicine inheritance and conservation of innovation. The theory of traditional Chinese medicine is the academic topic of Systematic research from Academician Wu Yiling in the 1970s. Through more than 40 years of hard work innovation, the "linked disease" has finally stretched the scattered record in the history of the Chinese national medicine. System theory of treatment value.

The "three -dimensional three -dimensional network system" framework is proposed to study the physiological function of the collateral veins and the onset of the vein, the pathogenesis, syndrome differentiation and treatment of the pathogenesis of the vein, the establishment of the "Cover Cover" system, and the establishment of cardiovascular and cerebrovascular diseases, diabetes and Its complications, tumors, influenza and other ancients called the diseased treatment methods of traditional diseases that are called linked diseases, publishing the monographs of the "List Diseases"; constructing the theory of guiding vascular disease prevention and treatment Effective new ways, publish the monograph of the "Polaris theory"; systematically explain the occurrence of air lesions, development laws, basic pathological changes, clinical syndrome characteristics, and dialectical treatment of syndrome differentiation, effectively guide the treatment of modern major diseases such as nerves, endocrine, immune diseases and other major diseases , Publish the monograph on Qi Lian. "List Diseases" has become an innovative textbook for colleges and universities in higher medicine in the new century, and has started courses in more than 40 universities at home and abroad.

The "Listing theory and its application research" won the second prize of national scientific and technological progress. The "Chinese Medicine List Disease Diagnosis and Treatment Method" as the inheritance of Academician Wu Yiling was selected as a national intangible cultural heritage list.

The theoretical guidance of the new patent drug of the R & D patent, providing a more ideal choice for clinical treatment

The theoretical breakthrough is the cornerstone of Chinese medicine into productivity and industrialization. Under the guidance of the theory of the neat disease, 13 innovative patent traditional Chinese medicines are developed. Products cover six major types of diseases with high incidence of cardiovascular and cerebrovascular disease, diabetes, respiratory diseases, tumors, neuropathy, and urinary system diseases. A group of effective drugs for cardiovascular and cerebrovascular diseases, respiratory diseases, and diabetes for cardiovascular and cerebrovascular diseases, respiratory diseases, and diabetes are the effective drugs such as capsules, ginseng -pine cocoons capsules, Qiqiang Qiangxin capsules, Lianhua Qingjuan capsules (granules), and Jinlida particles.

In the past two years, Lianhua Qing Plague has played an important role in the global epidemic prevention and control work. As of now, it has been approved to be listed in nearly 30 countries and regions around the world. Approval of new crown pneumonia in Kuwait, Laos and other countries; selected for the whitening of anti -epidemic drugs released by the Ministry of Health of Uzbekistan; approved to enter the designated hospital in Thailand and Cambodia's new crown pneumonia, and was selected as home treatment plan released by the Ministry of Health. Essence

Tongxinluo Capsules, Yangzheng Capital Capsules and other varieties have been registered and sold in countries such as South Korea, Vietnam, Canada, Singapore, Indonesia and other countries.

Cover three types of Tongluo Capsules, Ginseng Yangxin Capsules, and Qiqiang Qiangxin Capsule, which is studied after the listing of "TCM Period Theory Construction and Guiding Micro Vehicle Lessic Prevention" project, which won the first prize of national science and technology progress in 2019. This is the only first national scientific and technological progress prize in the field of medical and health in my country. The award proves the clinical efficacy of Tongluo drugs in the prevention and control of cardiovascular and cerebrovascular diseases, and also explains the charm of combining Chinese medicine and modern technology.

The conference conducted in -depth exchanges on a series of innovative achievements in the theoretical research and obtained of linked disease, and provided new perspectives and new ideas for theoretical innovation of Chinese medicine.Inherit the essence and keep innovation.In the future, the transformation of the research and a series of innovative achievements of Chinese medicine neat disease will definitely promote the development of Chinese medicine to a new era.(Yanzhao Metropolis Daily Overview of Journalists Tan Yanan)

- END -